HIL recognized in Israel’s Personal Medicine / Longevity industry 2019 report
HIL is featured as one of 160 companies in the Aging Analytics Agency and Vetek association’s 2019 report on the Longevity Industry in Israel. The report is part of a collaborative project by the Global Longevity Consortium, consisting of the Biogerontology Research Foundation, Deep Knowledge Analytics, Aging Analytics Agency and the Longevity International platform.
According to Aging Analytics Agency and Vetek association “the Longevity Industry lies at the nexus of geroscience, advanced biomedicine, P3 (precision, preventive, and personalized) medicine, the AgeTech market, and finance”. HIL was recognized as a player in the Personalized Medicine ecosystem, with a solution that aims to provide cancer patients with a wide access to Proton Therapy – one of the most advanced and precise forms of radiation treatment for solid tumors. Proton Therapy reduces damage to surrounding healthy tissue, thereby reducing toxicities and improving patient survival and quality of life.